PROSTATE CANCER: ASSESSMENT OF RISK USING DIGITAL RECTAL EXAMINATION, TUMOR GRADE, PROSTATE-SPECIFIC ANTIGEN, AND SYSTEMATIC BIOPSY
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 38 (1) , 49-58
- https://doi.org/10.1016/s0033-8389(05)70149-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- PROSPECTIVE EVALUATION OF LATERAL BIOPSIES OF THE PERIPHERAL ZONE FOR PROSTATE CANCER DETECTIONJournal of Urology, 1998
- THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- OUTCOME BASED STAGING FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATEJournal of Urology, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Systematic 5 Region Prostate Biopsy is Superior to Sextant Method for Diagnosing Carcinoma of the ProstateJournal of Urology, 1997
- Preoperative Prediction of Tumor Heterogeneity and Recurrence After Radical Prostatectomy for Localized Prostatic Carcinoma with Digital Rectal Examination, Prostate Specific Antigen and the Results of 6 Systematic BiopsiesJournal of Urology, 1996
- Prediction of Progression Following Radical ProstatectomyThe American Journal of Surgical Pathology, 1996
- The Volume of Prostate Cancer in the Biopsy Specimen Cannot Reliably Predict the Quantity of Cancer in the Radical Prostatectomy Specimen on an Individual BasisJournal of Urology, 1995
- Cell Proliferation in CarcinogenesisScience, 1990
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987